Financhill
Sell
28

AXGN Quote, Financials, Valuation and Earnings

Last price:
$9.76
Seasonality move :
6.35%
Day range:
$9.63 - $10.00
52-week range:
$6.59 - $21.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.24x
P/B ratio:
4.21x
Volume:
560.3K
Avg. volume:
703.2K
1-year change:
24.52%
Market cap:
$444.1M
Revenue:
$187.3M
EPS (TTM):
-$0.15

Analysts' Opinion

  • Consensus Rating
    Axogen has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $24.29, Axogen has an estimated upside of 149.08% from its current price of $9.75.
  • Price Target Downside
    According to analysts, the lowest downside price target is $21.00 representing 100% downside risk from its current price of $9.75.

Fair Value

  • According to the consensus of 5 analysts, Axogen has 149.08% upside to fair value with a price target of $24.29 per share.

AXGN vs. S&P 500

  • Over the past 5 trading days, Axogen has underperformed the S&P 500 by -10.37% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Axogen does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Axogen has grown year-over-year revenues for 12 quarters straight. In the most recent quarter Axogen reported revenues of $48.6M.

Earnings Growth

  • Axogen earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Axogen reported earnings per share of -$0.08.
Enterprise value:
469.7M
EV / Invested capital:
--
Price / LTM sales:
2.24x
EV / EBIT:
486.23x
EV / Revenue:
2.41x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2,115.77x
Price / Operating cash flow:
43,774.23x
Enterprise value / EBITDA:
53.45x
Gross Profit (TTM):
$144.3M
Return On Assets:
-3.7%
Net Income Margin (TTM):
-3.68%
Return On Equity:
-7.2%
Return On Invested Capital:
-4.88%
Operating Margin:
-3.42%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $144.2M $163.7M $194.5M $41.4M $48.6M
Gross Profit $111.8M $126M $144.3M $32.6M $34.9M
Operating Income -$25.7M -$18.7M -$388K -$4.6M -$1.7M
EBITDA -$19.4M -$9.9M $8.8M -$2.4M $298K
Diluted EPS -$0.58 -$0.50 -$0.15 -$0.15 -$0.08
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $135.1M $112.5M $88.7M $78.7M $93.1M
Total Assets $197.4M $198M $189.5M $186.5M $196.2M
Current Liabilities $22.3M $22.9M $21.2M $22.9M $21.7M
Total Liabilities $77.7M $94.2M $92M $93.4M $90.8M
Total Equity $119.7M $103.9M $97.5M $93.2M $105.4M
Total Debt $32.1M $45M $45.9M $46.8M $47.7M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$12.4M -$10.6M $3.6M -$12.3M -$13.2M
Cash From Investing $3.3M $16.8M -$5.7M -$3.3M $1.3M
Cash From Financing $2.3M $1.5M $4.5M $204K $2.4M
Free Cash Flow -$32.6M -$22.3M -$222K -$13.6M -$13.8M
AXGN
Sector
Market Cap
$444.1M
$33.4M
Price % of 52-Week High
46.43%
46.84%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
24.52%
-37.4%
Beta (5-Year)
1.055
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $10.46
200-day SMA
Sell
Level $15.14
Bollinger Bands (100)
Sell
Level 12.86 - 18.92
Chaikin Money Flow
Buy
Level 23.2M
20-day SMA
Sell
Level $10.93
Relative Strength Index (RSI14)
Sell
Level 27.37
ADX Line
Sell
Level 41.34
Williams %R
Buy
Level -93.8462
50-day SMA
Sell
Level $13.53
MACD (12, 26)
Sell
Level -0.97
25-day Aroon Oscillator
Sell
Level -96
On Balance Volume
Neutral
Level 36.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.6669)
Buy
CA Score (Annual)
Level (-0.1454)
Buy
Beneish M-Score (Annual)
Level (-2.748)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.5635)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Stock Forecast FAQ

In the current month, AXGN has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AXGN average analyst price target in the past 3 months is $24.29.

  • Where Will Axogen Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Axogen share price will rise to $24.29 per share over the next 12 months.

  • What Do Analysts Say About Axogen?

    Analysts are divided on their view about Axogen share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Axogen is a Sell and believe this share price will drop from its current level to $21.00.

  • What Is Axogen's Price Target?

    The price target for Axogen over the next 1-year time period is forecast to be $24.29 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is AXGN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Axogen is a Buy. 5 of 5 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of AXGN?

    You can purchase shares of Axogen via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Axogen shares.

  • What Is The Axogen Share Price Today?

    Axogen was last trading at $9.76 per share. This represents the most recent stock quote for Axogen. Yesterday, Axogen closed at $9.75 per share.

  • How To Buy Axogen Stock Online?

    In order to purchase Axogen stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Is Gamestop’s Bitcoin Strategy Going To Succeed?
Is Gamestop’s Bitcoin Strategy Going To Succeed?

When GameStop (NYSE: GME) announced in Q1 that its board had…

How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock